Nuvation Bio Inc. (NUVB) Operating cash flow 2020–2025
Nuvation Bio Inc. (NUVB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$173.4MFY2025 · since FY2020: -$36.5M → -$173.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$173.4M | -33.0% |
| FY2024 | -$130.4M | -91.8% |
| FY2023 | -$68.0M | +29.2% |
| FY2022 | -$96.1M | -40.9% |
| FY2021 | -$68.2M | -86.7% |
| FY2020 | -$36.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NUVB financial trends
NUVB RevenueNUVB Net incomeNUVB Net marginNUVB Gross profitNUVB Gross marginNUVB Operating incomeNUVB Operating marginNUVB Free cash flowNUVB Capital expendituresNUVB Return on equityNUVB Stock buybacksNUVB Dividends paidNUVB Total assetsNUVB Total liabilitiesNUVB Shareholders’ equityNUVB overview →